Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 12605
Country/Region: Kenya
Year: 2014
Main Partner: CARE International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $4,418,170 Additional Pipeline Funding: $64,940

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

CARE supports implementation and expansion of high quality HIV prevention, care and treatment services in Kisii County of Western Kenya.

CARE’s project goals include increasing the quality, access and utilization of HIV prevention, care and treatment services at community and facility levels; and strengthening the capacity of indigenous organizations and the MOH to facilitate local ownership and sustainability in line with the national strategic plans and GHI principles. In addition, CARE aims at supporting the government in meeting the Millenium Development Goals 4, 5 and 6.

In support of one M&E system, the program supports the National M&E system by deploying health record information officers and data clerks, building health workers capacity on documentation and reporting, supporting roll out of MOH District Health Information System, scale-up of electronic medical records in facilities to allow for efficient reporting both to PEPFAR and MOH, and supporting patient outcome analysis to inform program improvement.

Strategies to reduce cost will include: support for government-led programs to avoid duplication, engagement of county governments to prioritize and allocate funds for HIV programming, use of roving clinicians in the decentralization of HIV services, decentralization of trainings to the districts and health facilities, and use of the e-learning platform to conduct continuous professional development and support for an integrated district mentorship program in order to build the capacity of district teams. CARE through sub-awards to the county/sub-county health management teams supports HIV services implementation, ensuring MOH ownership, leadership and sustainability.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $195,494
Care: TB/HIV (HVTB) $208,690
Care: Pediatric Care and Support (PDCS) $66,607
Testing: HIV Testing and Counseling (HVCT) $570,366
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $993,308
Treatment: Adult Treatment (HTXS) $2,235,060
Treatment: Pediatric Treatment (PDTX) $148,645
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 1,390
C2.1.D By Age: 15+ 2015 14,016
C2.1.D By Age/Sex: <15 Female 2015 695
C2.1.D By Age/Sex: <15 Male 2015 695
C2.1.D By Age/Sex: 15+ Female 2015 9,251
C2.1.D By Age/Sex: 15+ Male 2015 4,765
C2.1.D By Sex: Female 2015 9,946
C2.1.D By Sex: Male 2015 5,460
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 15,406
C2.1.D Sum of Age disaggregates 2015 15,406
C2.1.D Sum of Age/Sex disaggregates 2015 15,406
C2.1.D Sum of Sex disaggregates 2015 15,406
C2.1.D_NGI By Age: <15 2015 1,390
C2.1.D_NGI By Age: 15+ 2015 14,016
C2.1.D_NGI By Age/Sex: <15 Female 2015 695
C2.1.D_NGI By Age/Sex: <15 Male 2015 695
C2.1.D_NGI By Age/Sex: 15+ Female 2015 9,251
C2.1.D_NGI By Age/Sex: 15+ Male 2015 4,765
C2.1.D_NGI By Sex: Female 2015 9,946
C2.1.D_NGI By Sex: Male 2015 5,460
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 15,406
C2.1.D_NGI Sum of Age disaggregates 2015 15,406
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 15,406
C2.1.D_NGI Sum of Sex disaggregates 2015 15,406
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 15,406
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 14,635
C2.5.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 15,406
C2.5.D Number of HIV-positive patients in HIV care who started TB treatment 2015 293
CARE_CURR Age/sex: <1 Female 2015 23
CARE_CURR Age/sex: <1 Male 2015 23
CARE_CURR Age/sex: 1-4 Female 2015 151
CARE_CURR Age/sex: 1-4 Male 2015 159
CARE_CURR Age/sex: 10-14 Female 2015 209
CARE_CURR Age/sex: 10-14 Male 2015 210
CARE_CURR Age/sex: 15-19 Female 2015 185
CARE_CURR Age/sex: 15-19 Male 2015 112
CARE_CURR Age/sex: 20-24 Female 2015 769
CARE_CURR Age/sex: 20-24 Male 2015 208
CARE_CURR Age/sex: 25-49 Female 2015 6,570
CARE_CURR Age/sex: 25-49 Male 2015 3,127
CARE_CURR Age/sex: 5-9 Female 2015 277
CARE_CURR Age/sex: 5-9 Male 2015 268
CARE_CURR Age/sex: 50+ Female 2015 1,264
CARE_CURR Age/sex: 50+ Male 2015 1,080
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 660
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 660
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 8,788
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 4,527
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 14,635
CARE_CURR Sum of Age/Sex disaggregates 2015 14,635
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 14,635
CARE_NEW Age/sex: <1 Female 2015 4
CARE_NEW Age/sex: <1 Male 2015 4
CARE_NEW Age/sex: 1-4 Female 2015 29
CARE_NEW Age/sex: 1-4 Male 2015 29
CARE_NEW Age/sex: 10-14 Female 2015 38
CARE_NEW Age/sex: 10-14 Male 2015 38
CARE_NEW Age/sex: 15-19 Female 2015 40
CARE_NEW Age/sex: 15-19 Male 2015 18
CARE_NEW Age/sex: 20-24 Female 2015 73
CARE_NEW Age/sex: 20-24 Male 2015 72
CARE_NEW Age/sex: 25-49 Female 2015 1,104
CARE_NEW Age/sex: 25-49 Male 2015 615
CARE_NEW Age/sex: 5-9 Female 2015 49
CARE_NEW Age/sex: 5-9 Male 2015 49
CARE_NEW Age/sex: 50+ Female 2015 381
CARE_NEW Age/sex: 50+ Male 2015 118
CARE_NEW Aggregated Age/sex: <15 Female 2015 120
CARE_NEW Aggregated Age/sex: <15 Male 2015 120
CARE_NEW Aggregated Age/sex: 15+ Female 2015 1,598
CARE_NEW Aggregated Age/sex: 15+ Male 2015 823
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 2,661
CARE_NEW Sum of Age/sex disaggregates 2015 2,661
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 2,661
CARE_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 124
CARE_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing clinical care services 2015 124
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 124
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 124
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 124
CARE_SITE_den Sum of Denominator Site Support Type disaggregates 2015 124
FN_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 112
FN_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 124
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 112
FN_SITE Sum of Numerator Support Type disaggregates 2015 112
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 124
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 124
FN_THER Age: <1 2015 7
FN_THER Age: 1-4 2015 50
FN_THER Age: 15-17 2015 47
FN_THER Age: 18+ 2015 2,051
FN_THER Age: 5-14 2015 156
FN_THER Aggregated Age: <18 2015 260
FN_THER Aggregated Age: 18+ 2015 2,051
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2015 2,311
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2015 3,081
FN_THER Sum of Age disaggregates 2015 2,311
FN_THER Sum of Aggregated Age disaggregates 2015 2,311
FPINT_SITE By site support type: Direct Service Delivery (DSD): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 93
FPINT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported HIV service delivery points 2015 124
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 93
FPINT_SITE Service delivery type: Clinical 2015 93
FPINT_SITE Sum of Numerator Site Support Type disaggregates 2015 93
FPINT_SITE Sum of Service Delivery Type disaggregates 2015 93
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2015 124
FPINT_SITE_den Sum of Denominator Site Support Type disaggregates 2015 124
HTS_TST Age/sex: 1-4 Female 2015 6,654
HTS_TST Age/sex: 1-4 Female 2015 6,654
HTS_TST Age/sex: 1-4 Male 2015 6,654
HTS_TST Age/sex: 1-4 Male 2015 6,654
HTS_TST Age/sex: 10-14 Female 2015 4,753
HTS_TST Age/sex: 10-14 Female 2015 4,753
HTS_TST Age/sex: 10-14 Male 2015 4,753
HTS_TST Age/sex: 10-14 Male 2015 4,753
HTS_TST Age/sex: 15-19 Female 2015 9,507
HTS_TST Age/sex: 15-19 Female 2015 9,507
HTS_TST Age/sex: 15-19 Male 2015 9,507
HTS_TST Age/sex: 15-19 Male 2015 9,507
HTS_TST Age/sex: 20-24 Female 2015 23,765
HTS_TST Age/sex: 20-24 Female 2015 23,765
HTS_TST Age/sex: 20-24 Male 2015 23,765
HTS_TST Age/sex: 20-24 Male 2015 23,765
HTS_TST Age/sex: 25-49 Female 2015 38,024
HTS_TST Age/sex: 25-49 Female 2015 38,024
HTS_TST Age/sex: 25-49 Male 2015 38,024
HTS_TST Age/sex: 25-49 Male 2015 38,024
HTS_TST Age/sex: 5-9 Female 2015 2,852
HTS_TST Age/sex: 5-9 Female 2015 2,852
HTS_TST Age/sex: 5-9 Male 2015 2,852
HTS_TST Age/sex: 5-9 Male 2015 2,852
HTS_TST Age/sex: 50+ Female 2015 9,506
HTS_TST Age/sex: 50+ Female 2015 9,506
HTS_TST Age/sex: 50+ Male 2015 9,506
HTS_TST Age/sex: 50+ Male 2015 9,506
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 14,259
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 14,259
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 80,802
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 80,802
HTS_TST Aggregated Age/sex: <15 Female 2015 14,259
HTS_TST Aggregated Age/sex: <15 Male 2015 14,259
HTS_TST Aggregated Age/sex: 15+ Female 2015 80,802
HTS_TST Aggregated Age/sex: 15+ Male 2015 80,802
HTS_TST By Test Result: Negative 2015 182,517
HTS_TST By Test Result: Negative 2015 182,517
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 190,122
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 190,122
HTS_TST Sum of Age/Sex disaggregates 2015 190,122
HTS_TST Sum of Age/Sex disaggregates 2015 190,122
HTS_TST Sum of Aggregated Age/Sex <15 2015 28,518
HTS_TST Sum of Aggregated Age/Sex <15 2015 28,518
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 161,604
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 161,604
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 190,122
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 190,122
HTS_TST Sum of Test Result disaggregates 2015 190,122
HTS_TST Sum of Test Result disaggregates 2015 190,122
HTS_TST_POS By Test Result: Positive 2015 7,605
HTS_TST_POS By Test Result: Positive 2015 7,605
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 124
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 124
LAB_CAP Sum of Site Support Type disaggregates 2015 124
PMTCT_ARV Life-long ART (including Option B+) 2015 1,814
PMTCT_ARV Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 605
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 2,419
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 2,419
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 968
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 846
PMTCT_ARV Sum of New and Current disaggregates 2015 1,814
PMTCT_ARV Sum of Regimen Type disaggregates 2015 2,419
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 1,814
PMTCT_ARV_NGI Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 605
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 2,419
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 2,419
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 968
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 846
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 1,814
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 2,419
PMTCT_EID By infants who received a virologic test within 2 months of birth 2015 1,451
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 484
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 97
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 2,419
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 1,935
PMTCT_EID Sum of Infant Age disaggregates 2015 1,935
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 124
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 124
PMTCT_SITE Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 124
PMTCT_SITE Sum of Numerator Support Type disaggregates 2015 124
PMTCT_SITE Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 124
PMTCT_SITE_den Sum of Denominator Support Type disaggregates 2015 124
PMTCT_STAT By: Known positives at entry 2015 1,137
PMTCT_STAT By: Number of new positives identified 2015 1,282
PMTCT_STAT Number of new ANC and L&D clients 2015 50,641
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 50,641
PMTCT_STAT Sum of Positives Status disaggregates 2015 2,419
PMTCT_STAT_NGI By: Known positives at entry 2015 1,137
PMTCT_STAT_NGI By: Number of new positives identified 2015 1,282
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 50,641
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 50,641
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 2,419
QI_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 99
QI_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, HTC 2015 124
QI_SITE Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months 2015 99
QI_SITE Sum of Numerator Site Support Type disaggregates 2015 99
QI_SITE Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 124
QI_SITE_den Sum of Denominator Site Support Type disaggregates 2015 124
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 124
SITE_SUPP By program area/support type: Food and Nutrition Direct Service Delivery (DSD) 2015 124
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 124
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 124
SITE_SUPP By program area/support type: PHDP/Family Planning & Integration Direct Service Delivery (DSD) 2015 124
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 124
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 124
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 124
SITE_SUPP Number of unique sites supported by PEPFAR 2015 124
TB_ART Age: 0-4 2015 16
TB_ART Age: 15+ 2015 598
TB_ART Age: 5-14 2015 45
TB_ART Aggregated Age: <15 2015 61
TB_ART Aggregated Age: 15+ 2015 598
TB_ART Female 2015 303
TB_ART Known HIV-positive 2015 264
TB_ART Male 2015 356
TB_ART Newly tested 2015 395
TB_ART Sum of Aggregated Age disaggregates 2015 659
TB_ART Sum of Sex disaggregates 2015 659
TB_ART Sum of Test Status disaggregates 2015 659
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2015 732
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 659
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units 2015 124
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 124
TB_ARTSITE Sum of Numerator Site Support Type disaggregates 2015 124
TB_ARTSITE The number of PEPFAR-supported TB basic management units 2015 124
TB_ARTSITE The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 124
TB_ARTSITE_den Sum of Denominator Site Support Type disaggregates 2015 124
TB_SCREEN Age: <1 2015 44
TB_SCREEN Age: 1-4 2015 300
TB_SCREEN Age: 10-14 2015 408
TB_SCREEN Age: 15-19 2015 281
TB_SCREEN Age: 20-24 2015 939
TB_SCREEN Age: 25-49 2015 9,207
TB_SCREEN Age: 5-9 2015 529
TB_SCREEN Age: 50+ 2015 2,196
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 1,281
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 12,623
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 14,635
TB_SCREEN Sex: Female 2015 8,971
TB_SCREEN Sex: Male 2015 4,933
TB_SCREEN Sum of Age disaggregates 2015 1,562
TB_SCREEN Sum of Aggregated Age disaggregates 2015 13,904
TB_SCREEN Sum of Sex disaggregates 2015 13,904
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 13,904
TX_CURR Age/Sex: <1 Female 2015 23
TX_CURR Age/Sex: <1 Male 2015 23
TX_CURR Age/Sex: 1-4 Female 2015 158
TX_CURR Age/Sex: 1-4 Male 2015 158
TX_CURR Age/Sex: 15+ Female 2015 8,868
TX_CURR Age/Sex: 15+ Male 2015 4,775
TX_CURR Age/Sex: 5-14 Female 2015 495
TX_CURR Age/Sex: 5-14 Male 2015 495
TX_CURR Aggregated Age/Sex: <1 Female 2015 23
TX_CURR Aggregated Age/Sex: <1 Male 2015 23
TX_CURR Aggregated Age/Sex: <15 Female 2015 676
TX_CURR Aggregated Age/Sex: <15 Male 2015 676
TX_CURR Aggregated Age/Sex: 15+ Female 2015 8,868
TX_CURR Aggregated Age/Sex: 15+ Male 2015 4,775
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 14,995
TX_CURR Percent children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 1
TX_CURR Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 1
TX_CURR Sum of age/sex disaggregates 2015 1,352
TX_CURR Sum of Aggregated Age/Sex <15 2015 1,352
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 13,643
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 14,995
TX_CURR_NGI Age/Sex: <1 Female 2015 23
TX_CURR_NGI Age/Sex: <1 Male 2015 23
TX_CURR_NGI Age/Sex: 1-4 Female 2015 158
TX_CURR_NGI Age/Sex: 1-4 Male 2015 158
TX_CURR_NGI Age/Sex: 15+ Female 2015 8,868
TX_CURR_NGI Age/Sex: 15+ Male 2015 4,775
TX_CURR_NGI Age/Sex: 5-14 Female 2015 495
TX_CURR_NGI Age/Sex: 5-14 Male 2015 495
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 23
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 23
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 676
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 676
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 8,868
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 4,775
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 14,995
TX_CURR_NGI Sum of Age/Sex disaggregates 2015 14,995
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 1,352
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 13,643
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 14,995
TX_DIST Number of Districts with documented routine supportive supervision visits to 75% of HIV care and treatment sites supported by the District 2015 1
TX_DIST Total number of PEPFAR supported District Health Offices 2015 1
TX_NEW Aggregated Grouping by Age: <1 Male 2015 66
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 66
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 221
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 221
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 1,747
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 940
TX_NEW Breastfeeding status 2015 85
TX_NEW By Age/Sex: <1 Female 2015 66
TX_NEW By Age/Sex: <1 Male 2015 66
TX_NEW By Age/Sex: 1-4 Female 2015 37
TX_NEW By Age/Sex: 1-4 Male 2015 37
TX_NEW By Age/Sex: 10-14 Female 2015 52
TX_NEW By Age/Sex: 10-14 Male 2015 52
TX_NEW By Age/Sex: 15-19 Female 2015 37
TX_NEW By Age/Sex: 15-19 Male 2015 23
TX_NEW By Age/Sex: 20-24 Female 2015 153
TX_NEW By Age/Sex: 20-24 Male 2015 42
TX_NEW By Age/Sex: 25-49 Female 2015 1,306
TX_NEW By Age/Sex: 25-49 Male 2015 650
TX_NEW By Age/Sex: 5-9 Female 2015 66
TX_NEW By Age/Sex: 5-9 Male 2015 66
TX_NEW By Age/Sex: 50+ Female 2015 251
TX_NEW By Age/Sex: 50+ Male 2015 225
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 3,129
TX_NEW Pregnancy status 2015 762
TX_NEW Sum of Age/Sex disaggregates 2015 3,129
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 3,129
TX_RET Age: 0-4 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 67
TX_RET Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 2,447
TX_RET Age: 5-14 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 182
TX_RET Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 248
TX_RET Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 2,447
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 2,696
TX_RET Pregnancy and breastfeeding status (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 1,512
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 3,172
TX_RET_den Age: 0-4 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 79
TX_RET_den Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 2,879
TX_RET_den Age: 5-14 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 214
TX_RET_den Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 292
TX_RET_den Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 2,879
TX_RET_den Pregnancy and breastfeeding status (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 1,779
TX_SITE By support type: Direct Service Delivery (DSD): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 87
TX_SITE By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites 2015 124
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 87
TX_SITE Sum of Numerator Site Support Type disaggregates 2015 87
TX_SITE Total number of PEPFAR-supported ART sites 2015 124
TX_SITE_den Sum of Denominator Site Support Type disaggregates 2015 124
Cross Cutting Budget Categories and Known Amounts Total: $637,598
Human Resources for Health $441,116
Gender: Gender Based Violence (GBV) $98,241
Post GBV Care
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $98,241
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Safe Motherhood
Tuberculosis
Family Planning